ArticleESMO open2025

Development of two machine learning models to predict conversion from primary HER2-0 breast cancer to HER2-low metastases: a proof-of-concept study.

F Miglietta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.